Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PGV 001 |
Trade Name | |
Synonyms | PGV001|PGV-001 |
Drug Descriptions |
PGV 001 is a personalized cancer vaccine comprised of synthetic peptides analogous to the neoantigens present on the patient's tumor, resulting in an immune response (PMID: 29403468). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C136466 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + PGV 001 | Atezolizumab PGV 001 | 0 | 1 |
CDX-301 + PGV 001 + Poly ICLC | CDX-301 PGV 001 Poly ICLC | 0 | 1 |
PGV 001 | PGV 001 | 0 | 0 |
PGV 001 + Poly ICLC | PGV 001 Poly ICLC | 0 | 1 |